Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
Kadhim Hayawi, Sakib Shahriar, Mohamed Adel Serhani, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1305-1305
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Efficacy and safety of COVID-19 vaccines
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, et al.
Cochrane library (2022) Vol. 2023, Iss. 3
Open Access | Times Cited: 251
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
Lorenzo Azzi, Daniela Dalla Gasperina, Giovanni Veronesi, et al.
EBioMedicine (2021) Vol. 75, pp. 103788-103788
Open Access | Times Cited: 186
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 85
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Multi-dimensional impacts of Coronavirus disease 2019 pandemic on Sustainable Development Goal achievement
Angkana Lekagul, Anamika Chattong, Putthipanya Rueangsom, et al.
Globalization and Health (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 30
Plant lectins as potent Anti-coronaviruses, Anti-inflammatory, antinociceptive and antiulcer agents
Emadeldin Hassan E. Konozy, Makarim Elfadil M. Osman, Amina Ibrahim Dirar
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 6, pp. 103301-103301
Open Access | Times Cited: 26
Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters
Felicity C. Stark, Bassel Akache, Lise Deschatelets, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity
Birgit M. Prü
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 2, pp. 065-065
Open Access | Times Cited: 22
COVID-19 and Multiorgan Response: The Long-Term Impact
Amer Harky, Avesta Ala'Aldeen, Sundas Butt, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101756-101756
Open Access | Times Cited: 12
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern
Bassel Akache, Tyler M. Renner, Matthew Stuible, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 20
Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19
Magan Solomon, Chen Liang
Virus Research (2022) Vol. 319, pp. 198882-198882
Open Access | Times Cited: 19
Omicron mutations increase interdomain interactions and reduce epitope exposure in the SARS-CoV-2 spike
Miłosz Wieczór, Phu K. Tang, Modesto Orozco, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105981-105981
Open Access | Times Cited: 10
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants
Flavia Chiuppesi, John A. Zaia, Katelyn Faircloth, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104745-104745
Open Access | Times Cited: 17
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis
Angela Meggiolaro, Monica Sañé Schepisi, Sara Farina, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1831-1841
Open Access | Times Cited: 17
Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach
Bushra Majeed, Jummy David, Nicola Luigi Bragazzi, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 9
The continuance intention to vaccinate against COVID-19: An empirical study from Malaysia
Li-Ann Hwang, Santha Vaithilingam, Jason Wei Jian Ng, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0301383-e0301383
Open Access | Times Cited: 2
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic
Yi Wang, Nantasit Luangasanatip, Wirichada Pan‐ngum, et al.
The European Journal of Health Economics (2022) Vol. 24, Iss. 5, pp. 735-748
Open Access | Times Cited: 12
Parental perceptions and the 5C psychological antecedents of COVID-19 vaccination during the first month of omicron variant surge: A large-scale cross-sectional survey in Saudi Arabia
Shuliweeh Alenezi, Mohammed Alarabi, Ayman Al‐Eyadhy, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 12
Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries
Jerome Nyhalah Dinga, Severin Kabakama, Dieudonné Lemuh Njimoh, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 34-34
Open Access | Times Cited: 7
Impacts of COVID-19 on Electric Vehicle Charging Behavior: Data Analytics, Visualization, and Clustering
Sakib Shahriar, A. R. Al-Ali
Applied System Innovation (2022) Vol. 5, Iss. 1, pp. 12-12
Open Access | Times Cited: 11
SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
Spyros Charonis, Lisa M. James, Apostolos P. Georgopoulos
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Evolution of SARS-CoV-2-specific CD4+ T cell epitopes
Marina Brand, Can Keşmir
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 283-293
Open Access | Times Cited: 6
Real-world effectiveness of COVID-19 vaccines: A retrospective cohort study of vaccinated individuals in Jazan, Saudi Arabia
Mohammed Y. Elamin, Yahya Maslamani, Mohammed A. Muaddi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 9, pp. 1512-1517
Open Access | Times Cited: 5
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, et al.
Reviews in Medical Microbiology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top